CircRNAs as potential biomarkers for the clinicopathology and prognosis of glioma patients: a meta-analysis
- PDF / 1,096,345 Bytes
- 10 Pages / 595.276 x 790.866 pts Page_size
- 16 Downloads / 224 Views
RESEARCH ARTICLE
Open Access
CircRNAs as potential biomarkers for the clinicopathology and prognosis of glioma patients: a meta-analysis Xiangqian Ding1†, Luyao Yang2†, Xin Geng1, Yanghong Zou1, Zhigang Wang1, Yao Li1, Renli Qi1, Wei Wang1, Jinghui Li1,3* and Hualin Yu1*
Abstract Background: An increasing number of studies have reported circular RNAs (circRNAs) as new potential biomarkers for the prognosis of gliomas. However, the overall prognostic value of circRNAs for glioma remains unclear. Therefore, this study is the first comprehensive evaluation of the clinicopathological and prognostic value of dysregulated circRNAs in the treatment of glioma patients. Methods: We systematically reviewed the online databases of PubMed, Web of Science, EMBASE, and Cochrane Library to identify studies that explored the relationship between circRNA expression and clinicopathological and prognostic factors in glioma through April 11, 2020. The quality of the included studies was evaluated by the Newcastle-Ottawa Scale (NOS) checklists. Clinicopathological features were assessed by pooled odds ratios (ORs) and 95% confidence intervals (CIs), and overall survival (OS) was assessed by hazard ratios (HRs) and 95% CIs. Results: Twenty-four eligible studies, including 22 studies of clinicopathological features, 1 diagnostic study, and 18 studies of prognosis, that included a total of 1390 patients were ultimately included in this study. Meta-analysis showed that highly expressed oncogenic circRNAs were significantly related to poor clinicopathological features (age: P = 0.026; tumor size: P ≤ 0.001; tumor grade: P ≤ 0.001; KPS: P = 0.012) and worse overall survival (OS) (HR = 2.01, 95% CI: 1.61–2.50, P ≤ 0.001). Moreover, we found that highly expressed tumor-suppressor circRNAs were related to better clinicopathological features (gender: P = 0.042; age: P = 0.014; tumor size: P = 0.022; tumor grade: P ≤ 0.001) and longer OS (HR = 2.70, 95% CI: 1.82–3.99, P ≤ 0.001). Conclusions: In conclusion, there is a significant correlation between the dysregulated expression of circRNAs and the clinicopathology and prognosis of glioma patients. Keywords: Circular RNA, Glioma, Prognosis, Clinicopathology, Meta-analysis
* Correspondence: [email protected]; [email protected]; [email protected]; [email protected] † Xiangqian Ding and Luyao Yang contributed equally to this work. 1 Second Department of Neurosurgery, Kunming Medical University First Affiliated Hospital, 650032, No.295, Xichang road, Kunming, Yunnan, China Full list of author information is available at the end of the article © The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creati
Data Loading...
